Dr. Gozani founded NeuroMetrix in 1996 and currently serves as Chairman of the board of directors and as our President and Chief Executive Officer.
Prior to forming the company, Dr. Gozani completed a neurophysiology research fellowship in the laboratory of Dr. Gerald Fischbach at Harvard Medical School. Dr. Gozani has published articles in the areas of basic and clinical neurophysiology, biomedical engineering and computational chemistry.
Dr. Gozani holds a B.A. degree in Computer Science, an M.S. degree in Biomedical Engineering and a Ph.D. in Neurobiology, from the University of California, Berkeley. He also received an M.D. from Harvard Medical School and the Harvard-MIT Division of Health Sciences and Technology at M.I.T.
Mr. Higgins brings to NeuroMetrix a broad set of financial management and operations skills from his experience with publicly traded companies in life sciences, specialty chemicals and financial services. He has extensive international experience with a particular emphasis on Japan, Southeast Asia and the Middle East.
Prior to joining NeuroMetrix, Mr. Higgins was Executive Vice President and Chief Financial Officer at Caliper Life Sciences. Inc, a provider of technology and services for life sciences research. Before Caliper, Mr. Higgins was Executive Vice President, Operations and Chief Financial Officer at V.I. Technologies, Inc. (“Vitex”), a biotechnology company addressing blood safety. Before Vitex, Mr. Higgins served at Cabot Corporation in various senior finance and operations roles. His last position at Cabot was President of Distrigas of Massachusetts Corporation, a subsidiary involved in the liquefied natural gas business, and prior to that he was responsible for Cabot’s Asia Pacific carbon black operations. Before joining Cabot, Mr. Higgins was with PricewaterhouseCoopers where he started his career.
Mr. Higgins holds a B.B.A. with honors from Boston University.
Mr. McGillin brings to NeuroMetrix over 20 years experience building successful, high-growth consumer brands most recently at Philips Oral Healthcare and at Johnson & Johnson.
At Philips Mr. McGillin was responsible for building the global oral care business of Sonicare to become the #1 brand in the nearly $1 billion dollar US power toothbrush market. During his career he has launched over 50 new products and product upgrades and managed businesses across markets including diagnostic imaging, healthcare informatics, medical devices, dental and consumer technology.
Mr. McGillin holds an MBA degree from Fordham University and a BS degree from Northeastern University.
Mr. MacDonald joined NeuroMetrix in September 2000 and has held several marketing and sales positions including Vice President of Marketing, Vice President of Healthcare Economics, Director of Marketing and Region Sales Manager.
Prior to joining NeuroMetrix, Mr. MacDonald held various marketing positions at Smith & Nephew Endoscopy, a world leader in minimally invasive surgical devices. These roles were focused on leading the company’s efforts to diversify into additional minimally invasive markets with the development of innovative surgical techniques and devices. Prior to Smith & Nephew, he served in multiple product management roles at Deknatel, Inc., a company specializing in the development of products for cardiovascular and other specialty surgery markets.
Mr. MacDonald holds a B.S. degree in Business Administration from Northeastern University.
Dr. Kong joined the company in 1999. In his role of SVP Research and Intellectual Property, he provides leadership for the Company's internal and external basic research functions. He manages the Company's intellectual property portfolio and is responsible for evaluation and licensing of outside intellectual property for the development of diabetic neuropathy related products.
Prior to joining the company, Dr. Kong was a tenured associate professor in the Department of Electrical Engineering at Northern Illinois University (Dekalb, IL). As a principal investigator, he successfully led many federally and industrially funded projects in signal processing research and bio-electric signal analysis applications. He has published numerous papers in leading signal processing, biomedical engineering, and clinical neurophysiology journals.
Dr. Kong received his Ph.D. from The Johns Hopkins University and MBA from Boston University. He is certified as professional risk manager by PRMIA. He is a senior member of IEEE and a member of Eta Kappa Nu and Beta Gamma Sigma.